A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia.Published in:Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06774-8By:Yasara, Nirmani;Wickramarathne, Nethmi;Mettananda, Chamila;Silva, Ishari;Hameed, Nizri;Attanayaka, Kumari;Rodrigo, Rexan;Wickramasinghe, Nirmani;Perera, Lakshman;Manamperi, Aresha;Premawardhena, Anuja;Mettananda, SachithPublication type:Article